Registro Italiano Dei Pazienti Affetti da Dolore Cronico - Trial NCT06228300
Access comprehensive clinical trial information for NCT06228300 through Pure Global AI's free database. This phase not specified trial is sponsored by Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva and is currently Not yet recruiting. The study focuses on Chronic Pain. Target enrollment is 2500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva
Timeline & Enrollment
N/A
Feb 01, 2024
Apr 01, 2026
Primary Outcome
Characterization of the profile of patients admitted to pain clinics in Italy: number of patients admitted,Characterization of the profile of patients admitted to pain clinics in Italy: type of pain.,Characterization of the profile of patients admitted to pain clinics in Italy: proportion of patients who reach a clinically significant outcome. ; time in which a clinically significant improvement will be achieved,Characterization of the profile of patients admitted to pain clinics in Italy: type of prescribed therapies (pharmacological, neuromodulatory or implant) necessary to achieve a clinically significant improvement,Characterization of the profile of patients admitted to pain clinics in Italy: time in which a clinically significant improvement will be achieved
Summary
The goal of this Multicenter, non-profit, noninterventional, prospective observational cohort
 study is to create a register of patients suffering from Chronic Pain of any origin in
 subject with diagnosis of Chronic Pain according to the IASP19 criteria (Subjects 4 years
 old - NRS 4)
 
 The main question[s] it aims to answer are:
 
 Identify the profiles of patients belonging to pain therapy centers Evaluate the proportion
 of patients who reach the outcome of 30 or 50% improvement Evaluate the healthcare resources
 used in terms of number of accesses and time needed to achieve the best outcome (30 or 50%
 improvement) Identify patient profiles in terms of clinically significant outcomes in
 relation to baseline characteristics and specific treatments performed and their intermediate
 surrogate outcomes in relation to specific patterns Describe the relevant clinical variables
 in the study population. In particular, the absolute and relative frequencies of those
 clinical variables relevant to the effectiveness of the treatment will be described,
 categorized by type of treatment, and the timing of the start of treatment with respect to
 the onset of pain. The data collected may be used for predictive analyses Participants with a
 diagnosis of chronic pain (pain lasting 12 weeks) will be enrolled, regardless of the
 etiology, modality and age of onset.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06228300
Non-Device Trial